MCID: GST045
MIFTS: 62

Gastroenteritis

Categories: Gastrointestinal diseases

Aliases & Classifications for Gastroenteritis

MalaCards integrated aliases for Gastroenteritis:

Name: Gastroenteritis 12 76 55 43 44 15 73
Cholera Morbus 12 73
Infectious Colitis, Enteritis and Gastroenteritis 12

Classifications:



External Ids:

Disease Ontology 12 DOID:2326
ICD10 33 K52.9
MeSH 44 D005759
NCIt 50 C34632
SNOMED-CT 68 25374005

Summaries for Gastroenteritis

MedlinePlus : 43 Have you ever had the "stomach flu?" What you probably had was gastroenteritis - not a type of flu at all. Gastroenteritis is an inflammation of the lining of the intestines caused by a virus, bacteria or parasites. Viral gastroenteritis is the second most common illness in the U.S. The cause is often a norovirus infection. It spreads through contaminated food or water, and contact with an infected person. The best prevention is frequent hand washing. Symptoms of gastroenteritis include diarrhea, abdominal pain, vomiting, headache, fever and chills. Most people recover with no treatment. The most common problem with gastroenteritis is dehydration. This happens if you do not drink enough fluids to replace what you lose through vomiting and diarrhea. Dehydration is most common in babies, young children, the elderly and people with weak immune systems. NIH: National Institute of Diabetes and Digestive and Kidney Diseases

MalaCards based summary : Gastroenteritis, also known as cholera morbus, is related to eosinophilic gastroenteritis and colitis, and has symptoms including nausea and vomiting, constipation and fever. An important gene associated with Gastroenteritis is ANPEP (Alanyl Aminopeptidase, Membrane), and among its related pathways/superpathways are Innate Immune System and PEDF Induced Signaling. The drugs Fentanyl and Infliximab have been mentioned in the context of this disorder. Affiliated tissues include testes, kidney and small intestine, and related phenotypes are digestive/alimentary and immune system

Disease Ontology : 12 A gastrointestinal system infectious disease that involves inflammation of the lining of the stomach and small and large intestines, which is caused by viruses, bacteria, or parasites. Chemicals and drugs also cause gastroenteritis. The symptoms include diarrhea, loss of appetite, nausea, vomiting, cramps, and discomfort in the abdomen.

Wikipedia : 76 Gastroenteritis, also known as infectious diarrhea, is inflammation of the gastrointestinal tract -- the... more...

Related Diseases for Gastroenteritis

Diseases related to Gastroenteritis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 523)
# Related Disease Score Top Affiliating Genes
1 eosinophilic gastroenteritis 33.9 ALB CCL11 IL5 RNASE3 TSLP
2 colitis 31.1 CXCL8 IL10 IL1B IL4 IL6 TNF
3 esophagitis, eosinophilic, 1 30.5 CCL11 IL5 TSLP
4 reactive arthritis 30.5 CRP IL10 TNF
5 acute pancreatitis 30.4 CRP CXCL8 IL10 IL6
6 irritable bowel syndrome 30.3 IL10 MLN TNF
7 duodenal ulcer 30.3 CXCL8 IL1B TNF
8 arthritis 30.2 CXCL8 IL10 IL1B IL6 TNF
9 esophagitis 30.1 CCL11 CXCL8 IL1B IL5 IL6 TSLP
10 eosinophilic gastritis 30.0 CCL11 IL4 IL5
11 food allergy 30.0 ALB IL10 IL4 IL5 RNASE3
12 cystitis 29.9 CRP CXCL8 IL6 TNF
13 graft-versus-host disease 29.9 IL10 IL1B IL6 TNF
14 obstructive jaundice 29.9 ALB CRP CXCL8 IL6 TNF
15 churg-strauss syndrome 29.9 IL10 IL5 RNASE3 TNF
16 milk allergy 29.8 IL10 IL4 IL5 RNASE3
17 exanthem 29.8 CRP IL6 TNF
18 hematopoietic stem cell transplantation 29.8 IL10 IL6 TNF
19 purpura 29.8 CRP IL6 TNF
20 cholangitis 29.8 ALB CRP FUT2 IL6 TNF
21 mixed connective tissue disease 29.8 IL10 IL6 TNF
22 protein-energy malnutrition 29.8 ALB IL6 TNF
23 laryngitis 29.8 IL1B IL6 TNF
24 viral infectious disease 29.8 CXCL8 IFNA1 IL10 IL1B IL4 IL6
25 dermatitis 29.8 CCL11 IL4 IL5 TSLP
26 perinatal necrotizing enterocolitis 29.7 CRP CXCL8 IL1B IL6 TNF
27 sclerosing cholangitis 29.7 ALB FUT2 TNF
28 eosinophilic pneumonia 29.7 CCL11 IL5 RNASE3
29 bullous pemphigoid 29.7 CCL11 IL5 RNASE3
30 proctitis 29.7 CRP RNASE3 TNF
31 cytomegalovirus infection 29.7 CXCL8 IL1B IL6 TNF
32 hypereosinophilic syndrome 29.6 CCL11 IFNA1 IL4 IL5 RNASE3
33 aseptic meningitis 29.6 CXCL8 IL10 IL1B TNF
34 pericarditis 29.5 CRP IL1B IL6 TNF
35 trichuriasis 29.5 CXCL8 IL10 RNASE3 TNF
36 appendicitis 29.5 TNF IL6 IL1B IL10 CXCL8 CRP
37 peritonitis 29.5 ALB CRP CXCL8 IL10 IL1B IL6
38 typhoid fever 29.5 ALB CRP IL1B IL6 TNF
39 parasitic protozoa infectious disease 29.5 IL10 IL1B IL4 IL6 TNF
40 tonsillitis 29.5 CXCL8 IL1B IL4 IL6 TNF
41 meningitis 29.4 TNF LACTB IL6 IL1B IL10 CXCL8
42 brucellosis 29.4 CRP CXCL8 IL10 IL4 IL6 TNF
43 ulcerative colitis 29.4 CRP CXCL8 IL10 IL1B IL6 TNF
44 aspergillosis 29.4 IL10 IL4 IL5 TNF
45 pyelonephritis 29.3 TNF IL6 IL1B IL10 CXCL8 CRP
46 intestinal disease 29.3 ALB CRP CXCL8 IL10 IL1B IL6
47 inflammatory bowel disease 29.2 ALB CCL11 CRP CXCL8 IL10 IL1B
48 noonan syndrome 1 29.2 CXCL8 IFNA1 IL1B IL6 TNF
49 asthma 29.2 CCL11 CXCL8 IL10 IL1B IL4 IL5
50 allergic asthma 29.2 CCL11 IL10 IL4 IL5 RNASE3 TSLP

Graphical network of the top 20 diseases related to Gastroenteritis:



Diseases related to Gastroenteritis

Symptoms & Phenotypes for Gastroenteritis

UMLS symptoms related to Gastroenteritis:


nausea and vomiting, constipation, fever, abdominal pain, pruritus, diarrhea, icterus, signs and symptoms, digestive, dyspepsia, heartburn, gastrointestinal gas, gastric irritation, abdominal cramps

MGI Mouse Phenotypes related to Gastroenteritis:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 digestive/alimentary MP:0005381 9.81 ALB FUT2 IL10 IL23A IL4 IL5
2 immune system MP:0005387 9.73 ANPEP CCL11 CRP FUT2 IL10 IL1B
3 neoplasm MP:0002006 9.17 ALB IL10 IL1B IL23A IL5 IL6

Drugs & Therapeutics for Gastroenteritis

Drugs for Gastroenteritis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 837)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 437-38-7 3345
2
Infliximab Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 170277-31-3
3
Iron Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 7439-89-6 23925
4
Nystatin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 1400-61-9 11953884
5
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 22916-47-8 4189
6
Certolizumab pegol Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 428863-50-7
7
Hydrocortisone acetate Approved, Vet_approved Phase 4,Phase 1,Phase 2,Not Applicable 50-03-3
8
Prednisone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 53-03-2 5865
9
Hydrocortisone Approved, Vet_approved Phase 4,Phase 1,Phase 2,Not Applicable 50-23-7 5754
10
Adalimumab Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 331731-18-1 16219006
11
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 50-24-8 5755
12
Prednisolone phosphate Approved, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 302-25-0
13
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 83-43-2 6741
14
Methylprednisolone hemisuccinate Approved Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 2921-57-5
15
Metronidazole Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 443-48-1 4173
16
Ciprofloxacin Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 85721-33-1 2764
17
Amoxicillin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 26787-78-0 33613
18
Ursodeoxycholic acid Approved, Investigational Phase 4,Phase 3 128-13-2 31401
19
Ceftriaxone Approved Phase 4,Not Applicable 73384-59-5 5479530 5361919
20
Mirtazapine Approved Phase 4 61337-67-5, 85650-52-8 4205
21
Mianserin Approved, Investigational Phase 4 24219-97-4 4184
22
Histamine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 51-45-6, 75614-87-8 774
23
Benzocaine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 94-09-7, 1994-09-7 2337
24 tannic acid Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
25
Azathioprine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 446-86-6 2265
26
Rabeprazole Approved, Investigational Phase 4,Phase 2,Phase 3,Not Applicable 117976-89-3 5029
27
Clarithromycin Approved Phase 4,Phase 3,Phase 2,Not Applicable 81103-11-9 84029
28
Copper Approved, Investigational Phase 4 7440-50-8 27099
29
Zinc Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 7440-66-6
30
leucovorin Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 58-05-9 6006 143
31
Tocopherol Approved, Investigational Phase 4,Phase 2,Phase 3,Not Applicable 1406-66-2 14986
32
Clofazimine Approved, Investigational Phase 4,Phase 3 2030-63-9 2794
33
Rifabutin Approved, Investigational Phase 4,Phase 3 72559-06-9 6323490
34
Ertapenem Approved, Investigational Phase 4,Phase 2,Not Applicable,Early Phase 1 153832-46-3 150610
35
Trimebutine Approved Phase 4 39133-31-8
36
Lansoprazole Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 103577-45-3 3883
37
Dexlansoprazole Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 103577-45-3, 138530-94-6 9578005
38
Metoclopramide Approved, Investigational Phase 4,Phase 3,Not Applicable 364-62-5 4168
39
Ondansetron Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 99614-02-5 4595
40
Dopamine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 51-61-6, 62-31-7 681
41
Loperamide Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 53179-11-6 3955
42
Calcium Carbonate Approved, Investigational Phase 4,Not Applicable 471-34-1
43
Propofol Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 2078-54-8 4943
44
Omeprazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable,Early Phase 1 73590-58-6 4594
45
Ethanol Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1 64-17-5 702
46
Rosiglitazone Approved, Investigational Phase 4,Phase 1,Phase 2 122320-73-4 77999
47
Esomeprazole Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 161796-78-7, 119141-88-7 4594 9579578
48
Sucralfate Approved Phase 4,Phase 3,Early Phase 1 54182-58-0 0
49 Vedolizumab Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 943609-66-3
50
Methotrexate Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 59-05-2, 1959-05-2 126941

Interventional clinical trials:

(show top 50) (show all 3459)
# Name Status NCT ID Phase Drugs
1 Analgesic Efficacy of Intravenous Hyoscine-N-Butylbromide (HNB) in Abdominal Colic Associated With Acute Gastroenteritis Unknown status NCT02508142 Phase 4 Hyoscine-N-Butylbromide
2 Precision Dosing of Infliximab Versus Conventional Dosing of Infliximab Unknown status NCT02453776 Phase 4 PRECISION dosing Infliximab
3 Vitamin D Substitution During Winter Time Unknown status NCT02958501 Phase 4 Colecalciferol
4 Withholding Feeds During Red Blood Cell Transfusion and TRAGI Unknown status NCT02132819 Phase 4
5 Anemia in Inflammatory Bowel Disease Unknown status NCT02760940 Phase 4 oral liposomal iron
6 Oral Hygiene Regimen in Patients on HCT Unknown status NCT02662374 Phase 4 .02% Chlorohexidine Gluconate;3% Sodium Bicarbonate;Nystatin 10000U/ml;Supersaturated Calcium Phosphate
7 "Efficacy and Safety of Infliximab-biosimilar (Inflectra) Compared to Infliximab-innovator (Remicade) in Patients With Inflammatory Bowel Disease in Remission: the SIMILAR Trial" Unknown status NCT02452151 Phase 4 Infliximab-Biosimilar;Infliximab-Innovator
8 Effectiveness of Low Energy Laser Treatment in Oral Mucositis Induced by Chemotherapy and Radiotherapy in Head and Neck Cancer Unknown status NCT01876407 Phase 4
9 The Effect of Probiotics on Exacerbation of Inflammatory Bowel Disease Exacerbation (Crohn's Disease) Unknown status NCT01765998 Phase 4 Probiotic;Placebo
10 Does Clinical Response Correlate With Serum Certolizumab Levels? Unknown status NCT02597829 Phase 4 Certolizumab Pegol
11 The Effect of Probiotics on the Rate of Recovery of Inflammatory Bowel Disease Exacerbation, Endothelial Function, and Markers of Inflammation Unknown status NCT01078935 Phase 4
12 Effects of Enteral Nutrition and Corticosteroid on Intestinal Flora in Induction Remission of Crohn Disease in Adult Unknown status NCT02056418 Phase 4 corticosteroid
13 Discontinuation of Infliximab Therapy in Patients With Crohn's Disease During Sustained Complete Remission Unknown status NCT01817426 Phase 4 Infliximab
14 A Prospective, Placebo Controlled, Double-Blind, Cross-over Study on the Effects of a Probiotic Preparation (VSL#3) on Metabolic Profile, Intestinal Permeability, Microbiota, Cytokines and Chemokines Expression and Other Inflammatory Markers in Pediatric Patients With Crohn's Disease Unknown status NCT01632462 Phase 4 VSL#3
15 Optimizing Cimzia in Crohn's Patients Unknown status NCT01024647 Phase 4
16 Use of Combined Measurements of Serum Infliximab and Anti-infliximab Antibodies in the Treatment of Patients With Crohns Disease Failing Infliximab Therapy Unknown status NCT00851565 Phase 4
17 Evaluation of PET CT in the Management of Patients With Crohn's Disease. Unknown status NCT00731809 Phase 4
18 Adverse Effects of Glucocorticoid Therapy on Bone in Childhood Crohn's Disease Unknown status NCT00609752 Phase 4 prednisolone
19 VSL#3 Treatment in Children With Crohn's Disease Unknown status NCT00367705 Phase 4
20 Comparison of a Nutritional Anti-Inflammatory Treatment to Steroids for Pediatric Crohn's Disease - the Molecular Basis Unknown status NCT00265772 Phase 4 MODULEN IBD (R) (specific Enteral Nutrition);prednisolon
21 Diverticulitis: Antibiotics or Close Observation? Unknown status NCT01111253 Phase 4 Amoxicillin-clavulanate
22 Prucalopride Prior to Small Bowel Capsule Endoscopy Unknown status NCT02806206 Phase 4 Prucalopride;Placebo
23 Therapeutic Effect of Ursodeoxycholic Acid in Functional Dyspepsia Unknown status NCT03004118 Phase 4 Placebo Oral Tablet;Ursochol oral tablet
24 The Role of Short-course Ceftriaxone Therapy in the Treatment of Severe Nontyphoidal Salmonella Enterocolitis Unknown status NCT01278017 Phase 4 ceftriaxone
25 Mirtazapine Versus Placebo in Functional Dyspepsia Unknown status NCT01240096 Phase 4 Mirtazapine
26 Fecal Microbiota Transplantation for Ulcerative Colitis Through Colonic Transendoscopic Enteral Tubing Unknown status NCT02998112 Phase 4 fecal microbiota transplantation;Saline
27 Efficacy of Treatment With Berberine to Maintain Remission in Ulcerative Colitis Unknown status NCT02962245 Phase 4 berberine;regular treatment
28 Azathioprine Based on Endoscopy After Clinical Remission in Moderate to Severe Ulcerative Colitis Unknown status NCT02579733 Phase 4 Azathioprine;Placebo
29 Golimumab in Steroid-dependent Ulcerative Colitis: Induction and Maintenance of Clinical and Endoscopic Remission Unknown status NCT02412085 Phase 4 Golimumab
30 Physiological Intermolecular Modification Spectroscopy (PIMS) in Ulcerative Colitis With Golimumab Unknown status NCT02186886 Phase 4 Golimumab
31 Concomitant Therapy of H. Pylori Unknown status NCT01922765 Phase 4 amoxicillin, clarithromycin, metronidazole, rabeprazole
32 Clostridial Infection and Oral Lavage -Improving Treatment Before Illness Becomes Severe Unknown status NCT01630096 Phase 4 Nu-Lytely
33 Role of Healthy Bacteria in Ulcerative Colitis Unknown status NCT01479660 Phase 4 Probiotic
34 Trial of Captafer® vs. Oral Iron Sulfate in the Treatment of Iron Deficiency Anemia in Patients With IBD Unknown status NCT02774057 Phase 4 Captafer®;Iron Sulfate
35 Treatment of Crohn's Disease With an Antibiotic Regimen Directed Against Mycobacterium Avium Paratuberculosis Unknown status NCT00513552 Phase 4 Rifabutin, Clarithromycin, and Clofazimine
36 Antibiotics Versus Surgery in Acute Appendicitis Unknown status NCT01421901 Phase 4 Ertapenem
37 Trimebutine Maleate Combined With Rabeprazole in Patients With Grade A or B Reflux Esophagitis Whose Symptoms Refractory to Rabeprazole Unknown status NCT02986685 Phase 4 Trimebutine Maleate;rabeprazole
38 Treatment Effect Between Dexlansoprazole and Double-dose Lansoprazole in Obesity Patients With Reflux Esophagitis Unknown status NCT02759393 Phase 4 Dexlansoprazole;Lansoprazole
39 Study to Evaluate the Duration of Treatment With Ertapenem in Acute Attacks of Sigmoid Diverticulitis Unknown status NCT00097734 Phase 4 ertapenem
40 Impact of Systematic Infants Vaccination Against Rotavirus on Gastroenteritis Hospitalization: a Prospective Study in Brest District, France. Completed NCT00740935 Phase 4
41 Ondansetron Versus Metoclopramide in Treatment of Vomiting in Gastroenteritis Completed NCT01165866 Phase 4 Treatment 1. Metoclopramide;Treatment 2 Ondansetron
42 Efficacy and Safety of Probiotics in the Treatment of Acute Gastroenteritis in Children Completed NCT03539913 Phase 4
43 Novel Diagnostics and Probiotics to Improve Management of Paediatric Acute Gastroenteritis Completed NCT02025452 Phase 4
44 A Trial Comparing the Effect of Oral Dimenhydrinate Versus Placebo in Children With Gastroenteritis Completed NCT00124787 Phase 4 Dimenhydrinate;Placebo
45 Emergency Department Rapid Intravenous Rehydration (RIVR) for Pediatric Gastroenteritis Completed NCT00392145 Phase 4 Standard IV rehydration;Rapid intravenous rehydration (RIVR)
46 Efficacy and Safety of a New Oral Rehydration Solution (Hipp ORS 200 Apple) in Children With Acute Gastroenteritis Completed NCT01467570 Phase 4
47 Efficacy of Lactobacillus GG With Diosmectite in Treatment Children With Acute Gastroenteritis Completed NCT01657032 Phase 4
48 Ondansetron Administration to WELL Children With Gastroenteritis Associated Vomiting in EDs in Pakistan Completed NCT01870635 Phase 4 Ondansetron;Placebo
49 Ondansetron Administration to Children With Gastroenteritis, Vomiting and SOME Dehydration in EDs in Pakistan Completed NCT01870648 Phase 4 Ondansetron;Placebo
50 Evaluation Of Bacillus Clausii In Treatment Of Acute Diarrhea In Latin American Children Completed NCT02169817 Phase 4 Bacillus clausii;Oral Rehydration Therapy

Search NIH Clinical Center for Gastroenteritis

Inferred drug relations via UMLS 73 / NDF-RT 51 :


Cochrane evidence based reviews: gastroenteritis

Genetic Tests for Gastroenteritis

Anatomical Context for Gastroenteritis

MalaCards organs/tissues related to Gastroenteritis:

41
Testes, Kidney, Small Intestine, Bone, Lung, Liver, T Cells

Publications for Gastroenteritis

Articles related to Gastroenteritis:

(show top 50) (show all 1935)
# Title Authors Year
1
Epidermal growth factor receptor is a co-factor for transmissible gastroenteritis virus entry. ( 29879540 )
2018
2
A Case of Eosinophilic Gastroenteritis in Which Obstructive Jaundice Developed due to Invagination of the Duodenal Wall. ( 29434146 )
2018
3
Accuracy of pediatric residents in determination of dehydration in children with gastroenteritis. ( 29881534 )
2018
4
Pilot survey of norovirus in Northern Italy: an example of surveillance of norovirus gastroenteritis. ( 29307329 )
2018
5
Acute gastroenteritis in a pediatric population from Cali, Colombia in the post rotavirus vaccine era. ( 29908961 )
2018
6
Detection and molecular characterization of enteric viruses in children with acute gastroenteritis in Northern Italy. ( 29438743 )
2018
7
An unusual outbreak of rotavirus G8P[8] gastroenteritis in adults in an urban community, Singapore, 2016. ( 29902679 )
2018
8
Acute gastroenteritis: evidence-based management of pediatric patients. ( 29369591 )
2018
9
Characterization of a Vesivirus Associated with an Outbreak of Acute Hemorrhagic Gastroenteritis in Domestic Dogs. ( 29444830 )
2018
10
Vedolizumab Treatment May Reduce Steroid Burden and Improve Histology in Patients With Eosinophilic Gastroenteritis. ( 29596982 )
2018
11
Hospital care for viral gastroenteritis in socio-economic and geographical context in Sweden 2006-2013. ( 29863748 )
2018
12
Eosinophilic gastroenteritis presenting with gastric perforation. ( 29366927 )
2018
13
Diversity of rotavirus strains circulating in children under five years of age who presented with acute gastroenteritis before and after rotavirus vaccine introduction, University Teaching Hospital, Lusaka, Zambia, 2008-2015. ( 29907481 )
2018
14
Transmissible gastroenteritis virus N protein causes endoplasmic reticulum stress, up-regulates interleukin-8 expression and its subcellular localization in the porcine intestinal epithelial cell. ( 29909129 )
2018
15
Successful Food-Elimination Diet in an Adult with Eosinophilic Gastroenteritis. ( 29850645 )
2018
16
New viruses associated with canine gastroenteritis. ( 29428093 )
2018
17
Draft Genome Sequences of Two<i>Vibrio parahaemolyticus</i>Strains Associated with Gastroenteritis after Raw Seafood Ingestion in Colorado. ( 29348331 )
2018
18
Ascites in a Young Woman: A Rare Presentation of Eosinophilic Gastroenteritis. ( 29862093 )
2018
19
The NICE-GUT trial protocol: a randomised, placebo controlled trial of oral nitazoxanide for the empiric treatment of acute gastroenteritis among Australian Aboriginal children. ( 29391385 )
2018
20
Efficacy and Safety of Fixed Dose Combination of Drotaverine Hydrochloride (80 mg) and Paracetamol (500 mg) in Amelioration of Abdominal Pain in Acute Infectious Gastroenteritis: A Randomized Controlled Trial. ( 29968385 )
2018
21
Acute gastroenteritis: evidence-based management of pediatric patients [digest]. ( 29388753 )
2018
22
Diarrheagenic Escherichia Coli and Acute Gastroenteritis in Children in Davidson County, Tennessee, United States: A Case-Control Study. ( 29341983 )
2018
23
Impact on Health-Related Quality of Life in Adults with Eosinophilic Gastritis and Gastroenteritis: A Qualitative Assessment. ( 29476289 )
2018
24
Afebrile Benign Convulsion Associated With Mild Gastroenteritis: A Cohort Study in a Tertiary Children Hospital. ( 29881767 )
2018
25
Genomic characterization of circoviruses associated with acute gastroenteritis in minks in northeastern China. ( 29948383 )
2018
26
Eosinophilic Gastroenteritis and Colitis: Not Yet Ready for the Big Leagues. ( 29620603 )
2018
27
Two Gastroenteritis Outbreaks Caused by Sapovirus in Shenzhen, China. ( 29882310 )
2018
28
A life-devastating cause of gastroenteritis in an immunocompetent host: was it suspected? ( 29375867 )
2018
29
A foodborne acute gastroenteritis outbreak caused by GII.P16-GII.2 norovirus in a boarding high school, Beijing, China: a case-control study. ( 29970134 )
2018
30
Genetic diversity and clonal characteristics of ciprofloxacin-resistant Campylobacter jejuni isolated from Chilean patients with gastroenteritis. ( 29306004 )
2018
31
Takayasu's arteritis associated with eosinophilic gastroenteritis, possibly via the overactivation of Th17. ( 29942355 )
2018
32
Rapid intravenous rehydration of children with acute gastroenteritis and dehydration: a systematic review and meta-analysis. ( 29426307 )
2018
33
Relationship between Enteric Pathogen and Acute Gastroenteritis Disease Severity - A Prospective Cohort Study. ( 29964235 )
2018
34
Efficacy of Single Administration of High-dose Phenobarbital Suppository as Initial Therapy for Benign Infantile Convulsions with Mild Gastroenteritis. ( 29900149 )
2018
35
Evaluation of a New Multiplex Real-Time PCR Assay for Detecting Gastroenteritis-Causing Viruses in Stool Samples. ( 29401556 )
2018
36
Evidence of the impact of monovalent rotavirus vaccine on childhood acute gastroenteritis hospitalization in Togo. ( 29397224 )
2018
37
Household transmission of acute gastroenteritis during the winter season in Japan. ( 29865912 )
2018
38
Eosinophilic gastroenteritis: An unusual presentation of a rare disease. ( 29555104 )
2018
39
Protective Effects of Xyloglucan in Association with the Polysaccharide Gelose in an Experimental Model of Gastroenteritis and Urinary Tract Infections. ( 29932149 )
2018
40
Clinical outcome of recurrent afebrile seizures in children with benign convulsions associated with mild gastroenteritis. ( 29935410 )
2018
41
Complete Genome Sequence of a Novel Recombinant GII.P16-GII.1 Norovirus Associated with a Gastroenteritis Outbreak in Shandong Province, China, in 2017. ( 29439040 )
2018
42
Revisiting the winter burden of acute gastroenteritis on hospital beds in England: change in data collection supports analytical method for previously missing values. ( 29908252 )
2018
43
A case of multi-drug resistant ESBL-producing Shigella sonnei acute acalculous cholecystitis and gastroenteritis in a returned traveller. ( 30169854 )
2018
44
Comparative effectiveness and safety of interventions for acute diarrhea and gastroenteritis in children: A systematic review and network meta-analysis. ( 30517196 )
2018
45
An Infected Aortic Aneurysm After Successful Treatment of Nontyphoidal Salmonella Gastroenteritis. ( 29571675 )
2018
46
Eosinophilic gastroenteritis complicating acute calculus eosinophilic cholecystitis 6 months after cholecystectomy. ( 30370999 )
2018
47
Cytomegalovirus gastroenteritis with pyloric stenosis and persistent malabsorption in a patient with common variable immunodeficiency. ( 30403390 )
2018
48
Correction: Acute Infectious Gastroenteritis Potentiates a Crohn's Disease Pathobiont to Fuel Ongoing Inflammation in the Post-Infectious Period. ( 29709025 )
2018
49
Estimating the incidence of norovirus acute gastroenteritis among US and European international travelers to areas of moderate to high risk of traveler's diarrhea: a prospective cohort study protocol. ( 30509202 )
2018
50
Species C Rotaviruses in Children with Diarrhea in India, 2010-2013: A Potentially Neglected Cause of Acute Gastroenteritis. ( 29462971 )
2018

Variations for Gastroenteritis

Expression for Gastroenteritis

Search GEO for disease gene expression data for Gastroenteritis.

Pathways for Gastroenteritis

Pathways related to Gastroenteritis according to GeneCards Suite gene sharing:

(show top 50) (show all 64)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
14.11 ANPEP CCL11 CRP CXCL8 IFNA1 IL10
2
Show member pathways
13.75 CCL11 CXCL8 IFNA1 IL10 IL1B IL23A
3
Show member pathways
13.62 CCL11 CXCL8 IFNA1 IL10 IL1B IL23A
4
Show member pathways
13.49 CCL11 CXCL8 IL10 IL1B IL23A IL4
5
Show member pathways
13.44 CCL11 CXCL8 IFNA1 IL10 IL1B IL23A
6
Show member pathways
13.38 CCL11 CXCL8 IL10 IL1B IL23A IL4
7
Show member pathways
13.05 CXCL8 IFNA1 IL10 IL1B IL6 TNF
8 12.91 CXCL8 IFNA1 IL23A IL4 IL5 IL6
9
Show member pathways
12.9 CCL11 CXCL8 IFNA1 IL10 IL1B IL4
10
Show member pathways
12.87 CXCL8 IFNA1 IL1B IL4 IL6 TNF
11
Show member pathways
12.79 CXCL8 IFNA1 IL1B IL6 TNF
12
Show member pathways
12.69 IL10 IL1B IL23A IL4 IL5 IL6
13
Show member pathways
12.65 IL10 IL1B IL23A IL6 TNF
14 12.63 IFNA1 IL10 IL1B IL4 TNF
15
Show member pathways
12.54 IL10 IL1B IL4 IL5 IL6 TNF
16
Show member pathways
12.49 IFNA1 IL10 IL23A IL4 IL5 IL6
17
Show member pathways
12.44 ALB CRP IL1B IL4 IL6 TNF
18
Show member pathways
12.42 CCL11 CXCL8 IL1B IL4 IL5 IL6
19
Show member pathways
12.33 CXCL8 IL1B IL6 TNF
20 12.33 IFNA1 IL10 IL1B IL23A IL6 TNF
21
Show member pathways
12.32 IL10 IL1B IL23A IL6 TNF
22
Show member pathways
12.31 CXCL8 IFNA1 IL10 IL1B IL4 IL5
23
Show member pathways
12.3 IL10 IL1B IL4 TNF
24 12.29 CXCL8 IL10 IL1B IL6 TNF
25
Show member pathways
12.29 CCL11 CXCL8 IL1B IL4 IL6 TNF
26
Show member pathways
12.27 CXCL8 IL1B IL6 TNF
27
Show member pathways
12.17 IL10 IL1B IL23A IL6 TNF
28
Show member pathways
12.15 CCL11 CXCL8 IL10 IL1B IL23A IL4
29 12.12 CXCL8 IL1B IL4 IL6 TNF
30
Show member pathways
12.11 IL1B IL4 IL6 TNF
31 12.1 ANPEP IL10 IL4 IL5 IL6 TNF
32 12 CXCL8 IL1B IL6 TNF
33 12 CXCL8 IL10 IL1B IL6 TNF
34 11.97 CXCL8 IL1B IL23A IL6 TNF
35 11.97 ANPEP IL1B IL4 IL5 IL6 TNF
36 11.91 CXCL8 IL4 IL5 IL6
37
Show member pathways
11.88 CXCL8 IL23A IL6
38
Show member pathways
11.87 CXCL8 IL4 IL5 TNF
39 11.87 IL10 IL1B IL23A IL6 TNF
40 11.85 IL10 IL1B IL23A IL4 IL5 TNF
41 11.84 CXCL8 IL1B IL6
42 11.84 CXCL8 IL10 IL1B IL23A IL6 TNF
43 11.81 CCL11 CXCL8 IL10 IL1B IL23A IL4
44 11.78 CCL11 IL10 IL4 IL5
45
Show member pathways
11.78 CXCL8 IL1B IL6 TNF
46 11.76 CCL11 IL10 IL1B IL23A IL4 IL6
47 11.71 CXCL8 IL1B IL6 TNF
48 11.66 CXCL8 IL10 IL1B IL6 TNF
49 11.64 CXCL8 IL23A IL6
50 11.64 CCL11 CXCL8 IL6 TSLP

GO Terms for Gastroenteritis

Cellular components related to Gastroenteritis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular region GO:0005576 9.83 ALB CCL11 CRP CXCL8 IFNA1 IL10
2 extracellular space GO:0005615 9.5 ALB ANPEP CCL11 CRP CXCL8 IFNA1

Biological processes related to Gastroenteritis according to GeneCards Suite gene sharing:

(show all 44)
# Name GO ID Score Top Affiliating Genes
1 immune response GO:0006955 9.91 CCL11 CXCL8 IL10 IL1B IL23A IL4
2 cellular response to lipopolysaccharide GO:0071222 9.88 CXCL8 IL10 IL1B IL6 TNF
3 defense response to Gram-negative bacterium GO:0050829 9.87 IL23A IL6 RNASE3
4 defense response to Gram-positive bacterium GO:0050830 9.87 CRP IL6 RNASE3 TNF
5 neutrophil chemotaxis GO:0030593 9.86 CCL11 CXCL8 IL1B
6 positive regulation of inflammatory response GO:0050729 9.85 IL23A TNF TSLP
7 B cell differentiation GO:0030183 9.85 IFNA1 IL10 IL4
8 positive regulation of tyrosine phosphorylation of STAT protein GO:0042531 9.83 IL23A IL4 IL6 TSLP
9 humoral immune response GO:0006959 9.82 IFNA1 IL6 TNF
10 positive regulation of NIK/NF-kappaB signaling GO:1901224 9.81 IL1B IL23A TNF
11 response to glucocorticoid GO:0051384 9.81 IL10 IL1B IL6 TNF
12 inflammatory response GO:0006954 9.81 CCL11 CRP CXCL8 IL10 IL1B IL23A
13 positive regulation of interferon-gamma production GO:0032729 9.8 IL1B IL23A TNF
14 positive regulation of DNA-binding transcription factor activity GO:0051091 9.77 IL10 IL1B IL5 IL6 TNF
15 positive regulation of T cell proliferation GO:0042102 9.76 IL1B IL23A IL4 IL6
16 negative regulation of neurogenesis GO:0050768 9.75 IL1B IL6 TNF
17 positive regulation of neutrophil chemotaxis GO:0090023 9.73 CXCL8 IL1B IL23A
18 positive regulation of interleukin-6 production GO:0032755 9.73 IL1B IL6 TNF TSLP
19 positive regulation of chemokine production GO:0032722 9.72 IL6 TNF TSLP
20 positive regulation of glial cell proliferation GO:0060252 9.71 IL1B IL6 TNF
21 positive regulation of immunoglobulin secretion GO:0051024 9.69 IL5 IL6
22 positive regulation of podosome assembly GO:0071803 9.69 IL5 TNF
23 response to molecule of bacterial origin GO:0002237 9.68 CXCL8 IL10
24 positive regulation of granulocyte macrophage colony-stimulating factor production GO:0032725 9.68 IL1B IL23A
25 positive regulation of interleukin-13 production GO:0032736 9.67 IL4 TSLP
26 endothelial cell apoptotic process GO:0072577 9.67 IL10 TNF
27 positive regulation of heterotypic cell-cell adhesion GO:0034116 9.67 IL10 IL1B TNF
28 positive regulation of chemokine biosynthetic process GO:0045080 9.66 IL1B TNF
29 positive regulation of MHC class II biosynthetic process GO:0045348 9.65 IL10 IL4
30 regulation of establishment of endothelial barrier GO:1903140 9.65 IL1B TNF
31 cytokine-mediated signaling pathway GO:0019221 9.65 CCL11 CXCL8 IFNA1 IL10 IL1B IL23A
32 negative regulation of cytokine secretion involved in immune response GO:0002740 9.64 IL10 TNF
33 positive regulation of fever generation GO:0031622 9.63 IL1B TNF
34 chronic inflammatory response to antigenic stimulus GO:0002439 9.62 IL1B TNF
35 regulation of isotype switching GO:0045191 9.61 IL10 IL4
36 sequestering of triglyceride GO:0030730 9.61 IL1B TNF
37 type 2 immune response GO:0042092 9.6 IL10 IL4
38 positive regulation of calcidiol 1-monooxygenase activity GO:0060559 9.59 IL1B TNF
39 receptor biosynthetic process GO:0032800 9.58 IL10 TNF
40 negative regulation of lipid storage GO:0010888 9.58 CRP IL6 TNF
41 positive regulation of neuroinflammatory response GO:0150078 9.5 IL1B IL6 TNF
42 regulation of signaling receptor activity GO:0010469 9.4 CCL11 CXCL8 IFNA1 IL10 IL1B IL23A
43 positive regulation of transcription, DNA-templated GO:0045893 10.1 IL10 IL1B IL4 IL5 IL6 TNF
44 positive regulation of gene expression GO:0010628 10.06 CRP IL1B IL4 IL6 TNF

Molecular functions related to Gastroenteritis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cytokine activity GO:0005125 9.36 CCL11 CXCL8 IFNA1 IL10 IL1B IL23A
2 growth factor activity GO:0008083 9.26 IL10 IL4 IL5 IL6

Sources for Gastroenteritis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
13